130 related articles for article (PubMed ID: 30530045)
1. SUR2B/Kir6.1 channel openers correct endothelial dysfunction in chronic heart failure via the miR-1-3p/ET-1 pathway.
Wang S; Guo X; Long CL; Li C; Zhang YF; Wang J; Wang H
Biomed Pharmacother; 2019 Feb; 110():431-439. PubMed ID: 30530045
[TBL] [Abstract][Full Text] [Related]
2. Activation of SUR2B/Kir6.1 subtype of adenosine triphosphate-sensitive potassium channel improves pressure overload-induced cardiac remodeling via protecting endothelial function.
Tang Y; Long CL; Wang RH; Cui W; Wang H
J Cardiovasc Pharmacol; 2010 Oct; 56(4):345-53. PubMed ID: 20505525
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells.
Wang S; Long CL; Chen J; Cui WY; Zhang YF; Zhang H; Wang H
Acta Pharmacol Sin; 2017 Jan; 38(1):41-55. PubMed ID: 27890915
[TBL] [Abstract][Full Text] [Related]
4. Natakalim Ameliorates Isoproterenol-Induced Chronic Heart Failure by Protecting against Endothelial Dysfunction.
Zhong M; Zhou H; Long C; Zhang Y; Cui W; Zhang H; Wang H
Pharmacology; 2016; 98(3-4):99-110. PubMed ID: 27174236
[TBL] [Abstract][Full Text] [Related]
5. The SUR2B subunit of rat vascular KATP channel is targeted by miR-9a-3p induced by prolonged exposure to methylglyoxal.
Li SS; Wu Y; Jin X; Jiang C
Am J Physiol Cell Physiol; 2015 Jan; 308(2):C139-45. PubMed ID: 25354529
[TBL] [Abstract][Full Text] [Related]
6. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
7. Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim.
Pan Z; Huang J; Cui W; Long C; Zhang Y; Wang H
J Cardiovasc Pharmacol; 2010 Sep; 56(3):215-28. PubMed ID: 20410832
[TBL] [Abstract][Full Text] [Related]
8. Activation of SUR2B/Kir6.1-type K(ATP) channels protects glomerular endothelial, mesangial and tubular epithelial cells against oleic acid renal damage.
Zhao Y; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Nov; 28(6):572-6. PubMed ID: 23581188
[TBL] [Abstract][Full Text] [Related]
9. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide upregulates KATP channel expression in vascular smooth muscle cells of spontaneously hypertensive rats.
Sun Y; Huang Y; Zhang R; Chen Q; Chen J; Zong Y; Liu J; Feng S; Liu AD; Holmberg L; Liu D; Tang C; Du J; Jin H
J Mol Med (Berl); 2015 Apr; 93(4):439-55. PubMed ID: 25412775
[TBL] [Abstract][Full Text] [Related]
11. [Protective effects of SUR2B/Kir6.1 potassium channel opener natakalim against RAVECs injuries induced by hypoxia].
Wei H; Cao YQ; Zhang JD; Peng Z; Yang DF; Liu JY; Shi YP; Yang YL; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 May; 28(3):241-4. PubMed ID: 22860425
[TBL] [Abstract][Full Text] [Related]
12. Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy.
Zhou HM; Zhong ML; Zhang YF; Cui WY; Long CL; Wang H
Int J Mol Med; 2014 Nov; 34(5):1209-18. PubMed ID: 25215478
[TBL] [Abstract][Full Text] [Related]
13. Methylglyoxal-induced miR-223 suppresses rat vascular K
Jin X; Wu Y; Cui N; Jiang C; Li SS
Vascul Pharmacol; 2020; 128-129():106666. PubMed ID: 32151743
[TBL] [Abstract][Full Text] [Related]
14. A new ATP-sensitive potassium channel opener protects endothelial function in cultured aortic endothelial cells.
Wang H; Long C; Duan Z; Shi C; Jia G; Zhang Y
Cardiovasc Res; 2007 Feb; 73(3):497-503. PubMed ID: 17116295
[TBL] [Abstract][Full Text] [Related]
15. [Interventional effects of activating SUR2B/Kir6.1-type K
Zhao Y; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):604-610. PubMed ID: 37308403
[No Abstract] [Full Text] [Related]
16. Myorelaxant action of fluorine-containing pinacidil analog, flocalin, in bladder smooth muscle is mediated by inhibition of L-type calcium channels rather than activation of KATP channels.
Philyppov IB; Golub AА; Boldyriev OI; Shtefan NL; Totska K; Voitychuk OI; Shuba YM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):585-92. PubMed ID: 26976335
[TBL] [Abstract][Full Text] [Related]
17. Iptakalim: a new or just another KCO?
Costa AD
Cardiovasc Res; 2009 Aug; 83(3):417-8. PubMed ID: 19515796
[No Abstract] [Full Text] [Related]
18. Iptakalim, opener of K(ATP), reverses the enhanced expression of genes encoding K(ATP) subunits in spontaneously hypertensive rats.
Gao M; Xue H; Wang Y; Wang H
Life Sci; 2005 Oct; 77(22):2743-51. PubMed ID: 15964031
[TBL] [Abstract][Full Text] [Related]
19. Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues.
Ploug KB; Baun M; Hay-Schmidt A; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2010 Jul; 637(1-3):109-17. PubMed ID: 20361954
[TBL] [Abstract][Full Text] [Related]
20. Effects of ZD0947, a novel and potent ATP-sensitive K
Mori K; Yamashita Y; Teramoto N
Eur J Pharmacol; 2016 Nov; 791():773-779. PubMed ID: 27693800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
